socratis
E.g, in San Francisco's protocols, if a patient doesn't regain a pulse after 30 minutes of CPR, the patient is declared dead and not transported to the hospital (unless the base hospital requests transport, which is rare). See policy 4050-II-2 (Medical Indications).
https://www.sfdph.org/dph/files/EMS/Policy-Protocol-Manuals/...
From that perspective, I'm surprised that the old policy existed. With respect to getting a pulse back, there's not much that can be done in a hospital that can't be done in the field. (Of course, after a pulse returns, then the hospital can do lots of things that can't be done on-scene).
* inflammation (accounting for 29 percent of the cardiovascular disease risk reduction)
* glucose metabolism and insulin resistance (27.9 percent),
* and body max index (27.3 percent).
The team also found connections to blood pressure, various forms of cholesterol, branch-chain amino acids and other biomarkers, but found that these accounted for less of the association between Mediterranean diet and risk reduction."
The suggestion from the data being that inflammation and insulin resistance might be more important factors than the usual cholesterol panel that people tend to fixate on.
Of note is that that is in addition to (not instead of) standard care.
It's also interesting to see many people taking Metformin (which inhibits glucose production in the liver) preventatively.
My "extremely expensive" was unfair. Some quick searching suggests ~$650 for the transmitter ~$100/week for sensors. "Not cheap" would be more accurate.
Dexcom has a CGM system that hooks up to your phone/watch, but is only available with prescription (and is extremely expensive without coverage), so this is effectively only available if you already have severe health problems.
Some former Dexcom employees founded a startup some time ago to do CGM for preventative healthcare, but I haven't heard anything of where it went. http://mobihealthnews.com/32601/dexcom-alums-develop-blood-s...
There are probably others.
To me these sorts of subcutaneous CGM systems seem more convenient for users than other initiatives (e.g, the contact lens projects). The sensor stays embedded for a week at a time, you can sleep with it in, and you get measurements every 5 minutes or so.